BMAL1 and central nervous system cancer: In gliomas, the MVD of BMAL1− samples was 25.3 ± 10.93 and the MVD of and BMAL1+ samples was 43.75 ± 10.94, with a statistically significant difference (P < 0.05) (Figure 2B and 2C).